Literature DB >> 3094799

Relapse of duodenal ulcer: does it matter which drug is used in initial treatment?

J P Miller, E B Faragher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3094799      PMCID： PMC1341843          DOI： 10.1136/bmj.293.6555.1117

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  20 in total

1.  Augmented postprandial gastric acid secretion due to exposure to ranitidine in healthy subjects.

Authors:  K Frislid; E Aadland; A Berstad
Journal:  Scand J Gastroenterol       Date:  1986-01       Impact factor: 2.423

2.  Does the duodenal cell ever return to normal? A comparison between treatment with cimetidine and denol.

Authors:  M G Moshal; M A Gregory; C Pillay; J M Spitaels
Journal:  Scand J Gastroenterol Suppl       Date:  1979

3.  Cimetidine and colloidal bismuth in treatment of chronic duodenal ulcer. Comparison of initial healing and recurrence after healing.

Authors:  J Y Kang; D W Piper
Journal:  Digestion       Date:  1982       Impact factor: 3.216

4.  Long term cimetidine in the management of severe duodenal ulcer dyspepsia.

Authors:  G R Gray; I S Smith; I Mackenzie; G Gillespie
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

5.  Carbenoxolone maintenance in cimetidine-healed patients.

Authors:  M Guslandi; M Cambielli; A Tittobello
Journal:  Scand J Gastroenterol       Date:  1980       Impact factor: 2.423

6.  Controlled trial of maintenance cimetidine treatment in healed duodenal ulcer: short and long-term effects.

Authors:  M W Dronfield; A J Batchelor; W Larkworthy; M J Langman
Journal:  Gut       Date:  1979-06       Impact factor: 23.059

7.  Prevention of duodenal ulcer relapse by cimetidine: a one-year double-blind trial.

Authors:  D J Hetzel; D J Shearman; R Hecker; R Sheers
Journal:  Med J Aust       Date:  1979-06-02       Impact factor: 7.738

8.  Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate.

Authors:  D F Martin; D Hollanders; S J May; M M Ravenscroft; D E Tweedle; J P Miller
Journal:  Lancet       Date:  1981-01-03       Impact factor: 79.321

9.  Model of medical treatment for duodenal ulcer.

Authors:  R E Pounder
Journal:  Lancet       Date:  1981-01-03       Impact factor: 79.321

10.  Antacid/anticholinergic, cimetidine, and placebo in treatment of active peptic ulcers.

Authors:  M Ström; R Gotthard; G Bodemar; A Walan
Journal:  Scand J Gastroenterol       Date:  1981       Impact factor: 2.423
View more
  21 in total

1.  Helicobacter pylori and peptic ulcer recurrence.

Authors:  M Guslandi
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

2.  Anomalous short plasma elimination half life in a patient intoxicated with bismuth subcitrate.

Authors:  A J McLean; S Islam; J R Lambert
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

3.  Relapse rates after duodenal ulcer healing--apples or pears?

Authors:  D A Johnston; I N Marks
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

Review 4.  Gastric cytoprotection. What does it really mean for the prescriber?

Authors:  M Guslandi
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

5.  Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist.

Authors:  G M Fullarton; G McLauchlan; A Macdonald; G P Crean; K E McColl
Journal:  Gut       Date:  1989-04       Impact factor: 23.059

6.  Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer.

Authors:  K D Bardhan; C Dallaire; H Eisold; A E Duggan
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

Review 7.  Formulary management of antiulcer drugs: clinical considerations.

Authors:  S L Sankey; L S Friedman
Journal:  Pharmacoeconomics       Date:  1994-03       Impact factor: 4.981

Review 8.  Relapse rate as a major determinant of drug selection in peptic ulcer therapy.

Authors:  A J McLean; D M Harcourt; J J McNeil
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

9.  Healing of gastric body ulcer with gastroprotective versus antisecretory treatment.

Authors:  M Jablonská
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

10.  High-affinity binding of the basement membrane proteins collagen type IV and laminin to the gastric pathogen Helicobacter pylori.

Authors:  T J Trust; P Doig; L Emödy; Z Kienle; T Wadström; P O'Toole
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.